+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immuno Oncology Assays Market - Global Forecast 2026-2032- Product Image
Immuno Oncology Assays Market - Global Forecast 2026-2032- Product Image
New

Immuno Oncology Assays Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337689
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Advanced immuno-oncology assays have become essential tools in cancer translational research and clinical development. These assays drive operational efficiency and elevate the pace of program decision-making for organizations operating in pharmaceutical, biotechnology, and diagnostics sectors.

Market Snapshot: Immuno Oncology Assays Market

The Immuno Oncology Assays Market is expanding at a robust pace, valued at USD 8.33 billion in 2025 and projected to reach USD 23.16 billion by 2032, with a CAGR of 15.71%. Market growth is sustained by the increasing use of these assays in translational research, evolving clinical development processes, and growing demand for comprehensive immune profiling solutions. Broader adoption is supported by the need for precision immune monitoring and the ability of these assays to facilitate therapy innovation and streamline regulatory approvals. Pharmaceutical and diagnostic stakeholders increasingly recognize the operational and clinical gains offered by next‑generation immuno-oncology testing platforms.

Scope & Segmentation

  • Technology Types: Flow cytometry—including conventional and spectral variants—immunoassays such as ELISA and multiplex formats, mass cytometry, and next-generation sequencing platforms.
  • Product Classes: Instruments like automated systems and platform devices, along with consumables including probes, antibodies, reagents, and kits.
  • Sample Matrices: Blood, cell lines, and tissue samples, each with unique collection and validation requirements to ensure data integrity.
  • End Users: Academic institutes, research centers, diagnostic laboratories, hospitals, clinics, pharmaceutical companies, and biotech firms leveraging assay solutions for translational insights and operational efficiency.
  • Indications: Areas of primary focus involve breast cancer, hematologic malignancies, lung cancer, and melanoma, reflecting the clinical potential of immune profiling.
  • Applications: Biomarker discovery, companion diagnostics, cytokine analysis, immune monitoring, and tumor microenvironment analysis to advance targeted therapeutic strategies.
  • Regions: Americas, Europe Middle East & Africa, and Asia-Pacific, each exhibiting distinct market drivers and adoption patterns for immuno-oncology assay technologies.

Key Takeaways

  • Technological convergence—blending advanced cytometry with multiplex immunoassays and sequencing—drives new insights into tumor-immune interactions and strengthens clinical impact.
  • More mature regulatory guidance now integrates validation directly into the development of companion diagnostics, reducing the time between biomarker discovery and product approval.
  • Vendors align strategies around bundled solutions and analytic pipelines that support workflow reproducibility and promote automation, lowering variability across sites.
  • Successful assay adoption relies on analytical rigor, workflow throughput, solution interoperability, and the ability to generate actionable clinical data suitable for various user groups.
  • Regional dynamics matter: The Americas lead technology adoption and partnership density, EMEA prioritizes cost-effective workflow standardization, and Asia-Pacific captures growth via clinical research investment and expanded manufacturing.
  • Supplier engagement shifts toward stable, long-term partnerships, enhancing supply chain resilience and support for multicenter clinical operations.

Tariff Impact: Operational and Procurement Effects of 2025 US Tariff Shifts

Shifts in US tariffs in 2025 presented considerable challenges for immuno-oncology assay purchasers and suppliers. These changes disrupted imports, affecting consumables, reagents, and platform components essential to ongoing research and diagnostics. Organizations proactively responded by diversifying supply chains, reassessing sourcing strategies, and qualifying alternative vendors. Procurement committees shifted toward flexible procurement and lease models while prioritizing supplier diversity and contract renegotiation to address pricing volatility. Standardization efforts gained momentum, reducing reliance on single-source consumables and providing operational continuity amidst regulatory change.

Methodology & Data Sources

This report integrates primary interviews with procurement leads, laboratory directors, translational scientists, and clinical operations stakeholders. Secondary research aggregates peer-reviewed articles, regulatory filings, technical documentation, and comparative assessments. All findings have been cross‑validated for accuracy, with transparent identification of coverage boundaries in certain niche segments.

Why This Report Matters

  • Enables informed selection and sourcing of immuno-oncology assay technologies by clarifying trends, segment roles, and regional adoption factors.
  • Enhances procurement strategies and operational design with actionable insights on regulatory considerations, supply chain risk, and vendor positioning.
  • Supports executive decision-making by aligning technology adoption with quality benchmarks, continuity planning, and emerging regulatory requirements.

Conclusion

Strategic alignment of immuno-oncology assay adoption with supplier networks and collaborative operations positions stakeholders to maximize clinical value and sustain market leadership. Ongoing engagement and rigorous validation remain critical for delivering consistent translational impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Immuno Oncology Assays Market, by Technology Type
8.1. Flow Cytometry
8.1.1. Conventional Flow Cytometry
8.1.2. Spectral Flow Cytometry
8.2. Immunoassay
8.2.1. Elisa
8.2.2. Multiplex Immunoassay
8.3. Mass Cytometry
8.4. Next Generation Sequencing
8.4.1. Targeted Panel
8.4.2. Whole Exome Sequencing
8.4.3. Whole Genome Sequencing
9. Immuno Oncology Assays Market, by Product
9.1. Consumables
9.1.1. Probes And Antibodies
9.1.2. Reagents And Kits
9.2. Instruments
9.2.1. Automated Systems
9.2.2. Platform Based Instruments
10. Immuno Oncology Assays Market, by Sample Type
10.1. Blood
10.2. Cell Lines
10.3. Tissue
11. Immuno Oncology Assays Market, by End User
11.1. Academic And Research Institutes
11.1.1. Research Institutes
11.1.2. Universities
11.2. Diagnostic Laboratories
11.3. Hospitals And Clinics
11.4. Pharmaceutical And Biotech
12. Immuno Oncology Assays Market, by Indication
12.1. Breast Cancer
12.2. Hematologic Cancers
12.3. Lung Cancer
12.4. Melanoma
13. Immuno Oncology Assays Market, by Application
13.1. Biomarker Discovery
13.2. Companion Diagnostics
13.3. Cytokine Analysis
13.4. Immune Monitoring
13.5. Tumor Microenvironment Analysis
14. Immuno Oncology Assays Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Immuno Oncology Assays Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Immuno Oncology Assays Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Immuno Oncology Assays Market
18. China Immuno Oncology Assays Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Adaptive Biotechnologies Corporation
19.7. Agilent Technologies Inc.
19.8. Akoya Biosciences Inc.
19.9. Becton Dickinson and Company
19.10. Bio-Rad Laboratories Inc.
19.11. Danaher Corporation
19.12. DiaSorin S.p.A.
19.13. Foundation Medicine Inc.
19.14. Guardant Health Inc.
19.15. Illumina Inc.
19.16. Invivoscribe Inc.
19.17. Merck KGaA
19.18. Meso Scale Diagnostics LLC
19.19. Myriad Genetics Inc.
19.20. NanoString Technologies Inc.
19.21. NeoGenomics Laboratories
19.22. PerkinElmer Inc.
19.23. Qiagen N.V.
19.24. Quanterix Corporation
19.25. Roche Holding AG
19.26. Siemens Healthineers AG
19.27. Standard BioTools Inc.
19.28. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SPECTRAL FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SPECTRAL FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SPECTRAL FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MULTIPLEX IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MULTIPLEX IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MULTIPLEX IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MASS CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MASS CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TARGETED PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TARGETED PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TARGETED PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PROBES AND ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PROBES AND ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PROBES AND ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PLATFORM BASED INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PLATFORM BASED INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PLATFORM BASED INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CELL LINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CELL LINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HEMATOLOGIC CANCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HEMATOLOGIC CANCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HEMATOLOGIC CANCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CYTOKINE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CYTOKINE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CYTOKINE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 174. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 176. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 177. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 178. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 179. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 181. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 183. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 184. EUROPE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 200. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 201. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 202. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 203. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 204. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 205. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 206. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 207. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 209. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 210. AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 225. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 227. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 228. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 229. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 230. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 231. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 232. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 233. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 234. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 236. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 237. ASEAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 240. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 241. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 242. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 243. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 244. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 245. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 246. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 247. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 249. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 250. GCC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 264. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 266. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 267. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 268. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 269. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 270. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 271. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 272. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 273. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 274. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 275. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 276. BRICS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 277. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 278. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 279. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 280. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 281. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 282. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 283. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 284. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 285. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 286. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 288. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 289. G7 IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 290. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 292. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 293. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 294. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 295. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 296. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 297. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 298. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 299. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 301. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 302. NATO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 303. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 308. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 309. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 310. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 311. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 312. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 313. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 314. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 315. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 316. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 317. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 318. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE

Companies Mentioned

The key companies profiled in this Immuno Oncology Assays market report include:
  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies Inc.
  • Akoya Biosciences Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Foundation Medicine Inc.
  • Guardant Health Inc.
  • Illumina Inc.
  • Invivoscribe Inc.
  • Merck KGaA
  • Meso Scale Diagnostics LLC
  • Myriad Genetics Inc.
  • NanoString Technologies Inc.
  • NeoGenomics Laboratories
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Quanterix Corporation
  • Roche Holding AG
  • Siemens Healthineers AG
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.57 Billion
Forecasted Market Value ( USD ) by 2032 $ 23.16 Billion
Compound Annual Growth Rate15.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis - Product Image

Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis

  • Report
  • 472 Pages
  • Global
From
Immuno-Oncology Market - Global Forecast 2026-2032 - Product Image

Immuno-Oncology Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Immuno-oncology Clinical Trials Market - Global Forecast 2026-2032 - Product Image

Immuno-oncology Clinical Trials Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030 - Product Image

Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030

  • Report
  • Global
From
Precision Immuno-Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Precision Immuno-Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From

About the Immuno Oncology Assays Market

Immuno Oncology Assays are tests used to measure the immune system's response to cancer. These tests are used to identify biomarkers that can be used to predict the effectiveness of immunotherapy treatments. Immuno Oncology Assays are used to measure the activity of the immune system, such as the number of T-cells, the presence of antibodies, and the expression of cytokines. These tests can also be used to monitor the progression of cancer and to determine the best course of treatment. Immune Disorders Drugs are used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. Immuno Oncology Assays are used to measure the effectiveness of these drugs and to monitor the progression of the disease. Some companies in the Immuno Oncology Assays market include Agilent Technologies, Bio-Rad Laboratories, Illumina, Merck, and Qiagen. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.